391 related articles for article (PubMed ID: 18817579)
1. The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand.
Teerawattananon Y; Russell S
BMC Health Serv Res; 2008 Sep; 8():197. PubMed ID: 18817579
[TBL] [Abstract][Full Text] [Related]
2. A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health-care coverage decisions under the Universal Health Insurance Coverage scheme in Thailand.
Teerawattananon Y; Russell S
Value Health; 2008 Mar; 11 Suppl 1():S52-60. PubMed ID: 18387068
[TBL] [Abstract][Full Text] [Related]
3. Presentation of economic evaluation results.
Chaikledkaew U; Teerawattananon Y
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S66-73. PubMed ID: 19253489
[TBL] [Abstract][Full Text] [Related]
4. Policy making and roles of health technology assessment.
Tantivess S
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S88-99. PubMed ID: 19253491
[TBL] [Abstract][Full Text] [Related]
5. Designing evaluation studies to optimally inform policy: what factors do policy-makers in China consider when making resource allocation decisions on healthcare worker training programmes?
Wu S; Legido-Quigley H; Spencer J; Coker RJ; Khan MS
Health Res Policy Syst; 2018 Feb; 16(1):16. PubMed ID: 29471840
[TBL] [Abstract][Full Text] [Related]
6. Historical development of health technology assessment in Thailand.
Teerawattananon Y; Tantivess S; Yothasamut J; Kingkaew P; Chaisiri K
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():241-52. PubMed ID: 19527543
[TBL] [Abstract][Full Text] [Related]
7. Quality assessment of health economic evaluation.
Chaikledkaew U; Kittrongsiri K
J Med Assoc Thai; 2014 May; 97 Suppl 5():S113-8. PubMed ID: 24964708
[TBL] [Abstract][Full Text] [Related]
8. Presentation of economic evaluation results.
Chaikledkaew U
J Med Assoc Thai; 2014 May; 97 Suppl 5():S72-80. PubMed ID: 24964702
[TBL] [Abstract][Full Text] [Related]
9. Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.
Tantivess S; Teerawattananon Y; Mills A
Pharmacoeconomics; 2009; 27(11):931-45. PubMed ID: 19888793
[TBL] [Abstract][Full Text] [Related]
10. Health system and equity perspectives in health technology assessment.
Hanvoravongchai P
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
[TBL] [Abstract][Full Text] [Related]
11. Measurement of costs for health economic evaluation.
Riewpaiboon A
J Med Assoc Thai; 2014 May; 97 Suppl 5():S17-26. PubMed ID: 24964695
[TBL] [Abstract][Full Text] [Related]
12. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
[TBL] [Abstract][Full Text] [Related]
13. Bridging the gap: exploring the barriers to using economic evidence in healthcare decision making and strategies for improving uptake.
Merlo G; Page K; Ratcliffe J; Halton K; Graves N
Appl Health Econ Health Policy; 2015 Jun; 13(3):303-9. PubMed ID: 25288052
[TBL] [Abstract][Full Text] [Related]
14. Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers.
Zegeye EA; Mbonigaba J; Kaye SB; Wilkinson T
Appl Health Econ Health Policy; 2017 Feb; 15(1):33-43. PubMed ID: 27637919
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation: what does a nurse manager need to know?
Douglas HR; Normand C
J Nurs Manag; 2005 Sep; 13(5):419-27. PubMed ID: 16108780
[TBL] [Abstract][Full Text] [Related]
16. The 3C study: coverage cost and care of type 1 diabetes in China--study design and implementation.
McGuire H; Kissimova-Skarbek K; Whiting D; Ji L
Diabetes Res Clin Pract; 2011 Nov; 94(2):307-10. PubMed ID: 22056720
[TBL] [Abstract][Full Text] [Related]
17. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
Williams I; Bryan S; McIver S
J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
[TBL] [Abstract][Full Text] [Related]
18. Generalised cost-effectiveness analysis: an aid to decision making in health.
Hutubessy RC; Baltussen RM; Torres-Edejer TT; Evans DB
Appl Health Econ Health Policy; 2002; 1(2):89-95. PubMed ID: 14619255
[TBL] [Abstract][Full Text] [Related]
19. Development of oral health policy in Nigeria: an analysis of the role of context, actors and policy process.
Etiaba E; Uguru N; Ebenso B; Russo G; Ezumah N; Uzochukwu B; Onwujekwe O
BMC Oral Health; 2015 May; 15():56. PubMed ID: 25943102
[TBL] [Abstract][Full Text] [Related]
20. Reforming the health sector in Thailand: the role of policy actors on the policy stage.
Green A
Int J Health Plann Manage; 2000; 15(1):39-59. PubMed ID: 10947567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
